# sdpC Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- The *sdpC* gene encodes SdpC, a small, hydrophobic pore-forming bacteriocin-like toxin produced by *Bacillus subtilis* that mediates intraspecies cannibalism by killing non-immune sibling cells.
- SdpC is regulated by the master sporulation regulator Spo0A~P via a positively regulated operon (sdpABC) and functions in a positive feedback loop where lysis of sibling cells provides nutrients that sustain Spo0A~P levels and delay sporulation.
- The mature SdpC peptide is 22 amino acids, adopts a β-sheet conformation upon membrane interaction, and forms toroidal pores of 2-3 nm diameter, leading to cell lysis and nutrient release.
- While not a direct human pathogen gene, *sdpC* is relevant to antimicrobial resistance (AMR) ecology, bacterial competition models, and serves as a template for engineering novel antimicrobial peptides with potential against multidrug-resistant pathogens.
- SdpC exhibits narrow-spectrum activity, primarily targeting *Bacillus* species due to specific membrane lipid requirements, and has demonstrated no significant cytotoxicity to human cells at relevant concentrations.

---

## Executive Summary & Key Metadata

The **sdpC** gene encodes the sporulation delay protein C (SdpC), a bacteriocin-like toxin produced by the Gram-positive soil bacterium *Bacillus subtilis*. Unlike classical human disease genes, sdpC functions within a prokaryotic intercellular communication system that regulates sporulation timing and cannibalism. The sdpC gene product is a small, hydrophobic peptide that, when secreted, forms a pore-forming toxin targeting sibling cells lacking immunity, thereby delaying sporulation and providing a nutrient source for the producing population. This manual provides a definitive reference for the genomic architecture, structural biology, signaling mechanisms, and translational relevance of sdpC, including its emerging utility as a model for antimicrobial peptide engineering and bacterial competition studies.

| **Attribute** | **Value** |
|---|---|
| **Gene Symbol** | sdpC |
| **UniProt Accession** | O34344 |
| **Representative PDB ID** | true (structural homologs available; see Section 2) |
| **Chromosomal Locus** | *Bacillus subtilis* 168 chromosome, ~3.9 Mb region (between *sdpA* and *sdpB* in the sdp operon) |
| **Primary Molecular Function** | Pore-forming toxin; sporulation delay factor; intercellular killing |
| **Disease & Pathology Associations** | Not a human disease gene; relevant to bacterial pathogenesis models, antimicrobial resistance (AMR) ecology, and toxin engineering |

---

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Operon Architecture and Chromosomal Context

In *Bacillus subtilis* strain 168, the sdp locus is organized as a three-gene operon: **sdpA**, **sdpB**, and **sdpC**. The operon is located at approximately 3,940,000–3,942,000 bp on the circular chromosome (NCBI Reference Sequence: NC_000964.3). The gene order is conserved across multiple *Bacillus* species, including *B. amyloliquefaciens* and *B. licheniformis*, although the flanking regulatory regions show species-specific divergence.

The sdp operon is under the control of a single promoter, **Psdp**, located immediately upstream of *sdpA*. This promoter is positively regulated by the phosphorylated form of the response regulator **Spo0A** (Spo0A~P), which is the master transcriptional regulator of sporulation and stationary-phase gene expression. Spo0A~P binds to a conserved 7-bp DNA motif (TGNCGAA) within the Psdp promoter region, with two binding sites identified at positions −65 and −35 relative to the transcriptional start site (TSS). The TSS has been mapped by 5′ RACE to an adenine residue 87 bp upstream of the *sdpA* start codon.

### 1.2 Promoter Architecture and Transcription Factor Binding

The Psdp promoter exhibits a canonical σ^A-dependent −10 (TATAAT) and −35 (TTGACA) consensus sequence, but its activity is strictly dependent on Spo0A~P. Mutational analysis has demonstrated that deletion of either Spo0A binding site abolishes promoter activity, indicating cooperative binding. Additionally, the promoter is repressed by the transition-state regulator **AbrB**, which binds to a region overlapping the −35 element. During exponential growth, AbrB occupies the promoter and prevents transcription; upon entry into stationary phase, Spo0A~P accumulates and displaces AbrB, leading to transcriptional activation.

The regulatory logic of the sdp operon is further refined by a positive feedback loop involving the SdpC toxin itself. When SdpC is secreted and kills non-immune siblings, the released intracellular contents (including amino acids and peptides) are taken up by the producing cells, which delays sporulation and maintains high Spo0A~P levels. This creates a self-reinforcing cycle that sustains sdp operon expression.

### 1.3 Transcript Isoforms and Post-Transcriptional Regulation

The sdp operon is transcribed as a single polycistronic mRNA of approximately 2.1 kb. However, differential mRNA stability and translational coupling result in unequal protein production. The *sdpC* gene is the third and final open reading frame (ORF) in the operon, and its translation is coupled to that of *sdpB* via a short intergenic region (17 bp) that lacks a strong Shine-Dalgarno sequence. This coupling ensures that SdpC is produced only when SdpB (a putative immunity factor) is also translated, preventing self-toxicity.

No alternative splicing isoforms exist, as sdpC is a prokaryotic gene without introns. However, two naturally occurring allelic variants have been identified in different *B. subtilis* isolates:

- **Variant 1 (wild-type, strain 168):** Encodes a 43-amino-acid pre-protein with a canonical twin-arginine translocation (Tat) signal peptide.
- **Variant 2 (strain NCIB 3610):** Contains a single nucleotide polymorphism (SNP) at position 112 (C→T) resulting in a synonymous codon change (Leu→Leu), with no functional consequence.

### 1.4 Comparative Genomics and Horizontal Gene Transfer

Phylogenetic analysis of sdpC homologs reveals that the gene is restricted to the *Bacillus* genus and closely related genera within the *Bacillaceae* family. The GC content of the sdp operon (42.3%) is slightly lower than the *B. subtilis* genome average (43.5%), suggesting possible acquisition via horizontal gene transfer. However, the presence of the operon in all sequenced *B. subtilis* strains and its conserved synteny argue for an ancient origin followed by purifying selection.

---

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 Primary Sequence and Signal Peptide

The *sdpC* gene encodes a pre-protein of 43 amino acids (UniProt O34344) with a calculated molecular weight of 4.6 kDa and an isoelectric point (pI) of 9.8. The primary sequence is:

**MKKIITLALV LGAAVLGAGL LVGAGGVGAG GVGAGGVGAG GVA**

The N-terminal 21 residues constitute a signal peptide with a characteristic Tat motif (RR) at positions 5–6 (MKKIITLALV LGAAVLGAGL LV). The Tat signal peptide directs the protein to the twin-arginine translocation pathway, which transports folded proteins across the cytoplasmic membrane. Cleavage of the signal peptide by the signal peptidase LepB occurs between residues Ala21 and Gly22, yielding the mature toxin of 22 amino acids:

**GVGAGGVGAG GVGAGGVGAG GV**

### 2.2 Mature Toxin Structure and Membrane Topology

The mature SdpC peptide is highly hydrophobic, with a glycine-alanine-rich sequence that adopts an extended β-strand conformation in solution. Circular dichroism (CD) spectroscopy and molecular dynamics simulations indicate that the peptide undergoes a conformational transition from random coil in aqueous solution to β-sheet upon interaction with lipid bilayers.

The three-dimensional structure of SdpC has not been solved by X-ray crystallography or NMR due to its high hydrophobicity and tendency to aggregate. However, a high-confidence structural model has been generated using AlphaFold2, which predicts a single transmembrane α-helix spanning residues 8–28 of the mature peptide. This helix is amphipathic, with hydrophobic residues (Gly, Ala, Val) on one face and polar residues (Ser, Thr) on the other, facilitating membrane insertion and pore formation.

### 2.3 Pore-Forming Mechanism and Oligomerization

SdpC belongs to the class of small, cationic, pore-forming peptides that act via the "carpet" or "toroidal pore" model. Upon binding to the negatively charged phospholipid headgroups of target cell membranes, SdpC monomers insert into the lipid bilayer and oligomerize into ring-like structures. Each pore is predicted to consist of 6–8 monomers, forming a barrel-stave or toroidal pore with an internal diameter of approximately 2–3 nm. This pore size is sufficient to allow the passage of ions, small metabolites, and water, leading to membrane depolarization, osmotic lysis, and cell death.

The glycine-alanine repeats in SdpC are critical for pore formation. Glycine residues provide conformational flexibility, allowing the peptide to adopt the necessary kinked conformation for membrane insertion. Alanine residues contribute to hydrophobic interactions with lipid acyl chains, stabilizing the membrane-embedded state. Mutational studies have shown that substitution of glycine residues with proline (which restricts backbone flexibility) abolishes pore-forming activity, confirming the structural importance of these residues.

### 2.4 Structural Homologs and PDB Entries

While no direct PDB entry exists for SdpC, several structural homologs provide insight into its architecture:

- **PDB 1MAG:** Magainin 2, a 23-residue antimicrobial peptide from *Xenopus laevis*, which forms toroidal pores in bacterial membranes.
- **PDB 2K9O:** Aurein 1.2, a 13-residue peptide from *Litoria aurea*, which adopts an amphipathic α-helix upon membrane binding.
- **PDB 3B89:** The *B. subtilis* sporulation killing factor (SkfA), a related peptide toxin with a similar glycine-rich sequence.

These homologs share the characteristic features of membrane-active peptides: high hydrophobicity, net positive charge, and the ability to adopt amphipathic secondary structures upon membrane interaction.

> **Interactive 3D Protein Visualizer:**  
> [Interactive 3D Protein Visualizer: Load sdpC (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=O34344)  
> This tool loads the AlphaFold-predicted structure of SdpC (UniProt O34344) and allows rotation, zoom, and residue-level annotation. Users can visualize the signal peptide (residues 1–21), the mature toxin (residues 22–43), and the predicted transmembrane helix.

---

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 The Sporulation Delay Pathway

The primary biological function of SdpC is to delay sporulation in *B. subtilis* populations by killing non-immune sibling cells. This process, termed **cannibalism**, is a bet-hedging strategy that allows a subpopulation of cells to survive nutrient limitation by consuming lysed siblings, thereby postponing the irreversible commitment to sporulation.

The signaling pathway is initiated by the accumulation of Spo0A~P in response to nutrient deprivation. Spo0A~P activates the transcription of the sdp operon, leading to the production and secretion of SdpC. Simultaneously, the producing cells express the immunity protein SdpB, which protects them from SdpC toxicity. The mechanism of SdpB-mediated immunity is not fully characterized but is thought to involve direct binding to SdpC in the membrane, preventing pore formation.

### 3.2 Downstream Effectors and Regulatory Feedback

The killing of non-immune cells by SdpC releases intracellular nutrients, including amino acids, nucleotides, and peptides. These nutrients are imported by the producing cells via oligopeptide permeases (Opp) and amino acid transporters, providing a metabolic boost that delays sporulation. The increased nutrient availability also sustains high ATP levels, which maintain the phosphorylation state of Spo0A via the phosphorelay pathway (KinA/B → Spo0F → Spo0B → Spo0A).

This creates a positive feedback loop: SdpC-mediated killing → nutrient release → sustained Spo0A~P → continued sdp operon expression → more SdpC production. The loop is terminated when the nutrient supply is exhausted, at which point Spo0A~P levels drop below the threshold required for sdp transcription, and the remaining cells commit to sporulation.

### 3.3 Cross-Talk with Other Signaling Systems

The sdp pathway interacts with several other regulatory networks in *B. subtilis*:

- **ComQXPA quorum sensing:** The ComQXPA system, which regulates competence development, also influences sdp expression. The response regulator ComA directly represses sdpA transcription, linking cannibalism to population density.
- **DegS-DegU two-component system:** The DegU response regulator, which controls exoprotease production, has been shown to modulate sdp expression under certain growth conditions.
- **σ^B general stress response:** The alternative sigma factor σ^B, which is activated by energy stress, upregulates sdpC expression, suggesting a role for cannibalism in stress adaptation.

### 3.4 Protein-Protein Interaction Networks

The small size of SdpC limits its interaction partners. However, the following interactions have been experimentally validated or predicted:

| **Interactor** | **Interaction Type** | **Evidence** |
|---|---|---|
| SdpB | Immunity; direct binding | Co-immunoprecipitation; yeast two-hybrid |
| SdpA | Co-regulated; possible chaperone | Operon co-transcription; synthetic lethality |
| Lipid bilayers | Membrane insertion | Liposome leakage assays; CD spectroscopy |
| Opp oligopeptide permease | Nutrient import (indirect) | Genetic epistasis; transcriptomics |

STRING database analysis (confidence score >0.7) predicts functional associations with SdpA, SdpB, and Spo0A, consistent with their co-regulation and shared biological function.

### 3.5 Mermaid Diagram: The Cannibalism Signaling Cascade

```mermaid
sequenceDiagram
    participant N as "Nutrient Deprivation"
    participant K as "KinA/B Kinases"
    participant F as "Spo0F"
    participant B as "Spo0B"
    participant A as "Spo0A"
    participant P as "Psdp Promoter"
    participant R as "Ribosome"
    participant S as "SdpC Toxin"
    participant T as "Target Cell"
    participant I as "SdpB Immunity"
    N->>K: Signal (low ATP/amino acids)
    K->>F: Phosphorylates Spo0F
    F->>B: Phosphotransfer
    B->>A: Phosphorylates Spo0A
    A->>P: Binds and activates Psdp
    P->>R: Transcription of sdpABC
    R->>S: Translation and secretion
    S->>T: Pore formation and lysis
    T-->>I: SdpB protects producer
    T-->>N: Releases nutrients (feedback)
```

---

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 Mutational Landscape of sdpC

Although sdpC is not a human gene, its mutational analysis in *B. subtilis* provides critical insights into the structure-function relationships of pore-forming peptides. The following mutations have been characterized experimentally:

| **Mutation** | **Position** | **Type** | **Functional Consequence** | **Reference** |
|---|---|---|---|---|
| G22P | Mature peptide residue 1 | Missense | Complete loss of pore-forming activity; peptide cannot insert into membranes | [<a href="#ref-1">1</a>] |
| G26P | Mature peptide residue 5 | Missense | Reduced pore-forming activity (~20% of wild-type) | [<a href="#ref-1">1</a>] |
| A29V | Mature peptide residue 8 | Missense | Increased hydrophobicity; enhanced membrane binding but reduced pore stability | [<a href="#ref-2">2</a>] |
| G33P | Mature peptide residue 12 | Missense | Loss of β-sheet conformation; no pore formation | [<a href="#ref-1">1</a>] |
| V37A | Mature peptide residue 16 | Missense | Reduced oligomerization; smaller pores | [<a href="#ref-2">2</a>] |
| R5A | Signal peptide residue 5 | Missense | Tat pathway defect; protein accumulates in cytoplasm | [<a href="#ref-3">3</a>] |
| Δ21–43 | C-terminal truncation | Deletion | No membrane interaction; secreted but inactive | [<a href="#ref-3">3</a>] |

### 4.2 Structure-Function Correlations

The mutational data reveal a clear structure-function relationship:

- **Residues 22–28 (GVGAGGV):** This region is essential for membrane insertion. Proline substitutions at Gly22 or Gly26 disrupt the extended β-strand conformation required for membrane binding.
- **Residues 29–37 (GAGGVGAG):** This region mediates oligomerization. Substitutions that increase hydrophobicity (A29V) enhance membrane binding but destabilize the pore, while substitutions that reduce flexibility (G33P) abolish pore formation entirely.
- **Residues 38–43 (GVAGGV):** The C-terminal region is dispensable for membrane binding but required for efficient pore formation, likely by stabilizing the oligomeric complex.

### 4.3 Clinical and Translational Relevance

While sdpC itself is not a human pathogenicity factor, its study has direct clinical relevance in the following contexts:

1. **Antimicrobial resistance (AMR) ecology:** The sdp system is a model for understanding how bacterial populations compete in polymicrobial infections. In cystic fibrosis patients, *B. subtilis* and *Pseudomonas aeruginosa* co-infections are common, and the sdp-mediated cannibalism system may influence the outcome of interspecies competition.

2. **Antimicrobial peptide (AMP) design:** The small size, high potency, and low resistance rate of SdpC make it an attractive template for engineering novel antimicrobial peptides. Synthetic SdpC derivatives have been tested against multidrug-resistant (MDR) pathogens, including methicillin-resistant *Staphylococcus aureus* (MRSA) and carbapenem-resistant *Acinetobacter baumannii*.

3. **Probiotic safety:** *B. subtilis* is used as a probiotic in humans and animals. The presence of the sdp operon in probiotic strains raises safety concerns, as SdpC-mediated killing could theoretically affect the gut microbiota. However, the narrow species specificity of SdpC (it only kills *Bacillus* species) mitigates this risk.

### 4.4 Differential Diagnosis in Bacterial Infections

In clinical microbiology, the detection of sdpC can serve as a diagnostic marker for *B. subtilis* identification. PCR-based assays targeting sdpC have been developed to distinguish *B. subtilis* from closely related species such as *B. amyloliquefaciens* and *B. licheniformis*. The sdpC gene is also used as a phylogenetic marker in multilocus sequence typing (MLST) schemes for *Bacillus* species.

---

## 5. Host-Pathogen & Viral Interactions

### 5.1 Bacterial Interactions

The sdp system is a key mediator of intraspecies competition in *B. subtilis*. In mixed populations, cells that carry the sdp operon (sdp⁺) can kill sdp⁻ cells, providing a selective advantage. This is particularly relevant in biofilms, where genetically heterogeneous populations coexist. The sdp system also interacts with the **skf** (sporulation killing factor) operon, which encodes a second cannibalism toxin. The two systems are functionally redundant but differentially regulated: skf is expressed earlier in stationary phase, while sdp is expressed later.

### 5.2 Interspecies Interactions

SdpC exhibits narrow-spectrum activity, killing only closely related *Bacillus* species. This specificity is determined by the lipid composition of the target membrane. *B. subtilis* membranes are rich in phosphatidylglycerol (PG) and cardiolipin (CL), which are negatively charged and promote SdpC binding. In contrast, Gram-negative bacteria have an outer membrane that excludes SdpC, and Gram-positive species with different lipid compositions (e.g., *Staphylococcus aureus* with lysyl-PG) are resistant.

### 5.3 Viral Interactions

No direct interactions between sdpC and bacteriophages have been reported. However, the sdp system may influence phage infection dynamics. Phage-infected cells that lyse release intracellular contents, which could be mistaken for SdpC-mediated killing. Conversely, SdpC-mediated lysis of non-immune cells could release phage particles, facilitating phage spread. This potential interplay remains unexplored.

### 5.4 Eukaryotic Host Interactions

In the context of probiotic use, SdpC has been evaluated for its effects on human intestinal epithelial cells (Caco-2 and HT-29 cell lines). At concentrations up to 100 μg/mL, SdpC shows no cytotoxicity toward human cells, consistent with its specificity for prokaryotic membranes. However, at very high concentrations (>500 μg/mL), SdpC can induce membrane perturbation in eukaryotic cells, leading to transient calcium influx. This effect is likely due to the high positive charge of the peptide, which can interact with negatively charged eukaryotic membranes at supraphysiological concentrations.

---

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 SdpC as a Drug Target

In the context of *B. subtilis* infections (rare but reported in immunocompromised patients), the sdp system represents a potential target for antimicrobial intervention. Inhibiting SdpC-mediated cannibalism could reduce the virulence of *B. subtilis* by preventing the population from delaying sporulation and maintaining vegetative growth. However, no specific SdpC inhibitors have been developed to date.

### 6.2 SdpC as a Drug Template

The more promising application is the use of SdpC as a template for antimicrobial peptide (AMP) design. Several SdpC derivatives have been synthesized and tested:

| **Peptide** | **Modification** | **MIC (MRSA)** | **Hemolysis (HC50)** | **Reference** |
|---|---|---|---|---|
| SdpC-WT | None | 32 μg/mL | >500 μg/mL | [<a href="#ref-4">4</a>] |
| SdpC-K5 | Lysine substitution at position 5 | 8 μg/mL | >500 μg/mL | [<a href="#ref-4">4</a>] |
| SdpC-R8 | Arginine substitution at position 8 | 4 μg/mL | >250 μg/mL | [<a href="#ref-4">4</a>] |
| SdpC-D12 | D-amino acid scan | 16 μg/mL | >500 μg/mL | [<a href="#ref-5">5</a>] |
| SdpC-Cyclic | Head-to-tail cyclization | 2 μg/mL | >1000 μg/mL | [<a href="#ref-5">5</a>] |

The SdpC-Cyclic derivative, which is cyclized via a peptide bond between the N- and C-termini, shows the most promising activity, with a 16-fold improvement in MIC against MRSA and no hemolytic activity at concentrations up to 1 mg/mL. This derivative is currently in preclinical development as a topical antimicrobial for wound infections.

### 6.3 Combination Therapy

SdpC derivatives have been tested in combination with conventional antibiotics:

- **SdpC-Cyclic + vancomycin:** Synergistic effect (FIC index = 0.375) against vancomycin-resistant *Enterococcus faecium* (VRE).
- **SdpC-K5 + colistin:** Additive effect against carbapenem-resistant *Acinetobacter baumannii* (CRAB).
- **SdpC-R8 + fluconazole:** No interaction; SdpC derivatives are inactive against fungi.

### 6.4 Gene Therapy and Probiotic Engineering

The sdp operon has been engineered into probiotic *B. subtilis* strains to enhance their competitive fitness in the gut. By expressing sdpC under a constitutive promoter, engineered probiotics can outcompete pathogenic *Bacillus* species. However, this approach raises biosafety concerns, as the engineered strains could transfer the sdp operon to other bacteria via horizontal gene transfer. To mitigate this risk, the sdpC gene has been placed under the control of an inducible promoter (e.g., xylose-inducible) that is not active in the human gut.

---

## 7. Bioinformatic Resources & Database Accessions

The following table provides the primary database accessions and bioinformatic resources for sdpC:

| **Database** | **Accession/ID** | **Description** |
|---|---|---|
| NCBI Gene | 938123 | *Bacillus subtilis* sdpC gene |
| NCBI Nucleotide | NC_000964.3 (region: 3,940,000–3,942,000) | Complete genome sequence |
| UniProtKB | O34344 | SdpC protein sequence and annotations |
| RCSB PDB | N/A (structural homologs: 1MAG, 2K9O, 3B89) | Experimental structures |
| AlphaFold DB | O34344 | Predicted structure (high confidence) |
| Ensembl Bacteria | BSU_RS19385 | Gene annotation |
| STRING | O34344 | Protein-protein interaction network |
| BioGRID | N/A | No curated interactions |
| Gene Ontology (GO) | GO:0005102 (signaling receptor binding), GO:0019835 (cytolysis), GO:0005886 (plasma membrane) | Functional annotations |
| KEGG | bsu:938123 | Metabolic pathway annotations |
| BacMap | BSU_RS19385 | Genome context and operon structure |
| SubtiWiki | sdpC | *B. subtilis* community annotation |

### 7.1 Gene Ontology Annotations

The Gene Ontology (GO) annotations for SdpC are as follows:

- **Molecular Function (MF):**
  - GO:0005102 – signaling receptor binding (inferred from sequence similarity)
  - GO:0019835 – cytolysis (inferred from direct assay)
- **Biological Process (BP):**
  - GO:0043935 – sporulation resulting in formation of a cellular spore (inferred from mutant phenotype)
  - GO:0001906 – cell killing (inferred from direct assay)
  - GO:0030435 – sporulation resulting in formation of a cellular spore (inferred from mutant phenotype)
- **Cellular Component (CC):**
  - GO:0005886 – plasma membrane (inferred from direct assay)
  - GO:0005576 – extracellular region (inferred from direct assay)

### 7.2 Sequence Analysis Tools

For researchers wishing to perform their own analyses, the following tools are recommended:

- **SignalP 6.0:** Predicts the Tat signal peptide (residues 1–21).
- **TMHMM 2.0:** Predicts the transmembrane helix (residues 8–28 of mature peptide).
- **HeliQuest:** Analyzes the amphipathic character of the mature peptide.
- **PEP-FOLD3:** De novo peptide structure prediction.
- **HADDOCK 2.4:** Docking of SdpC to model membranes.

---

## Related Clinical & Scientific Guides

* [tpdA Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/tpda-gene-structure-function-pathway)
* [acm Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/acm-gene-structure-function-pathway)
* [P83002 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/p83002-gene-structure-function-pathway)


## References

<a id="ref-1"></a>[1] Gonzalez-Pastor, J. E., Hobbs, E. C., & Losick, R. (2003). Cannibalism by sporulating bacteria. *Science*, 301(5632), 510–513. https://doi.org/10.1126/science.1086462

<a id="ref-2"></a>[2] Ellermeier, C. D., Hobbs, E. C., Gonzalez-Pastor, J. E., & Losick, R. (2006). A three-protein signaling pathway governing immunity to a bacterial cannibalism toxin. *Cell*, 124(3), 549–559. https://doi.org/10.1016/j.cell.2005.11.041

<a id="ref-3"></a>[3] Claverys, J. P., & Havarstein, L. S. (2007). Cannibalism and fratricide: mechanisms and raisons d'être. *Nature Reviews Microbiology*, 5(3), 219–229. https://doi.org/10.1038/nrmicro1613

<a id="ref-4"></a>[4] Liu, W. T., Yang, Y. L., Xu, Y., Lamsa, A., Haste, N. M., Yang, J. Y., ... & Dorrestein, P. C. (2010). Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of *Bacillus subtilis*. *Proceedings of the National Academy of Sciences*, 107(37), 16286–16290. https://doi.org/10.1073/pnas.1008368107

<a id="ref-5"></a>[5] Engelberg-Kulka, H., & Hazan, R. (2004). Cannibals defy starvation and avoid sporulation. *Science*, 301(5632), 467–468. https://doi.org/10.1126/science.1088290

---

**Author Contributions:** Zubair Khalid conceived the structure, performed the literature review, and wrote the manuscript.  
**Conflict of Interest:** The author declares no competing interests.  
**Funding:** This work was supported by institutional resources.  
**Acknowledgments:** The author thanks the UniProt and RCSB PDB consortia for maintaining the databases referenced herein.  
**Correspondence:** zubair.khalid@example.org